Abstract
Objective
Our study investigated the immunity changes and life quality changes after the treatment of cytokine induced killer (CIK) cells for patients with malignant tumor after radiochemotherapy, and explored the therapeutic effects of CIK cells on these patients.
Methods
Thirty-one patients with malignant tumor after radiochemotherapy were treated with CIK cells. Before and after CIK cells being transfused back, the immunity indexes of the peripheral blood of these cases were detected and the changes of life quality of these cases were compared.
Results
After radiochemotherapy, the percentage of CD3+, CD4+ cells declined, the percentage of CD8+ cells rose; the ratio of CD4+/CD8+ declined, and the percentage of CD16+, CD56+ cells declined. As all the above indexes compared with that of normal people, the difference was significant (P < 0.05). After CIK cells therapy, the above indexes improved (P < 0.05). Life quality improved significantly after CIK cells therapy (P < 0.05).
Conclusion
Radiochemotherapy can inhibit the immunity in patients with malignant tumor. CIK cells therapy is safe and effective. It may improve the recent immunity and life quality of the patients, which suggesting that it may be an alternative maintenance treatment for patients with malignant tumor after radiochemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Schmidt-wolf GD, Negrin RS, Schmidt — wolf IG. Activated T cells and cytokine-induced CD3+CD56+ killer cells. Ann Hematol, 1997, 74: 51–56.
Thorne SH, Negrin RS, Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy. Science, 2006, 311: 1780–1784.
Gritzapis AD, Dimitroulopoulos D, Paraskevas E, et al. Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants. Cancer Immunol Immunother, 2002, 51: 440–448.
Duan XM, Tan Y, Fang YQ, et al. Study on change of T cell subsets and NK cells in peripheral blood from patients with tumor treated with CIK. Chin J Clin Oncol (Chinese), 2003, 30: 491–493.
Dong XL, Wang YJ, Sun XZ, et al. Research on T cells subsets and activity of immunoctyes of patients with lung cancer. J Xi’an Med Univ (Chinese), 1999, 20: 474–475.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tian, J., Teng, D. A clinical trial of cytokine induced killer cells treating patients with malignant tumor after radiochemotherapy. Chin. -Ger. J. Clin. Oncol. 9, 656–659 (2010). https://doi.org/10.1007/s10330-010-0691-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-010-0691-5